AkzoNobel has acquired the business of Integrated Botanical Technologies (IBT) and its unique technology for developing natural, solvent-free ingredients.
IBT’s patented Zeta Fraction technology advances the ability to selectively isolate intracellular components from living plants and marine sources. These ingredients are derived from living cells and isolated on the basis of their electrokinetic (zeta) potential. Zeta Fraction ingredients include only naturally occurring substances without any chemical modifications. “IBT’s technology is based on fundamental scientific principles that allow for the isolation of intracellular components in a manner that is extremely reproducible, sustainable and can be used for multiple industries and applications,” explained Dr Michael Koganov, one of IBT’s founders, who will be joining AkzoNobel and leading the Zeta Fraction technology platform across AkzoNobel businesses. “Once you understand Zeta Fraction technology, you will be amazed at the clever and cutting edge science,” said Rob Asselin, vice president of AkzoNobel Global Personal Care. “Zeta Fraction ingredients allow personal care formulators to harvest truly potent solutions from nature.” IBT, with production facilities in Ossining, New York, has been working directly with AkzoNobel Global Personal Care for the past five years, developing signature ingredients for selected customers that are currently being used in personal care. A new series of plant derived ingredients is planned for release to the general market in the fourth quarter of 2011. “This is just the beginning of an exciting new era of truly sustainable, highly reproducible ingredients for personal care,” said Asselin.
